Compare FTRA & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTRA | EIKN |
|---|---|---|
| Founded | 2026 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 283.5M | 316.3M |
| IPO Year | 2026 | 2026 |
| Metric | FTRA | EIKN |
|---|---|---|
| Price | $9.88 | $4.80 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 65.9K | ★ 511.7K |
| Earning Date | N/A | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.85 | $4.72 |
| 52 Week High | $10.23 | $16.50 |
| Indicator | FTRA | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 52.26 | 33.10 |
| Support Level | $9.85 | N/A |
| Resistance Level | $9.95 | $6.82 |
| Average True Range (ATR) | 0.03 | 0.63 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 7.89 | 3.10 |
FutureCorp Space Acquisition 1 is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.